Doylestown Health is consistent with the COVID-19 recommendations of the Centers for Disease Control (CDC)

Doylestown Health supports continued proactive efforts to prevent an uncontrolled outbreak among our most vulnerable populations, including unvaccinated adults as well as children under 5 who are ineligible for vaccination at this time.

For more Doylestown Health COVID-19 information, visit our COVID-19 Update page.

Doylestown Health
Thomas H. Vikoren, MD

Thomas H. Vikoren, MD

Orthopaedics, Orthopaedic Surgery

Clinical Services

Orthopedic Surgery, Orthopedics, Joint Replacement

Certifications

Board Certified: Orthopaedic Surgery

Education

University of Pittsburgh Medical School

Residency: Duke University Medical Center

Fellowship: Massachusetts General Hospital/Harvard Medical School

Gender

Male

Language

English

More About The Clinician

Dr. Vikoren specializes in hip and knee replacements as well as the repair of complex fractures, particularly around joint replacements. He earned his medical degree from the University of Pittsburgh Medical School and completed his residency training in orthopedic surgery at Duke University Medical Center in Durham, North Carolina. He successfully completed a prestigious fellowship in Adult Reconstructive Hip and Knee Surgery at Massachusetts General Hospital/Harvard Medical School in Boston.

While at medical school, Dr. Vikoren was inducted into the Alpha Omega Alpha Honor Society and received the University of Pittsburgh Medical School Alumni Association Research Scholarship. He has participated in a variety of research projects and presented on his findings. He has authored several articles for professional publications.

Dr. Vikoren became interested in orthopedics while studying Physics at Dartmouth College. Orthopedics allows him to combine his mechanical interests with his desire to positively impact people's lives. He is particularly interested in the science behind joint replacements and the improvements in both implant technology and surgical techniques. At the same time, he is cautious not to embrace new technologies without having seen proven results.